Melanoma Posts on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

Can removal of metastasis improve overall survival in patients with melanoma who responded to targeted therapy?

Can removal of metastasis improve overall survival in patients with melanoma who responded to targeted therapy?

Posted by on Sep 19, 2020 in Melanoma | 0 comments

In a nutshell This study was carried out to assess the effectiveness of metastasectomy (ME; surgical removal of tumors that have spread from the original tumor location) for patients with advanced melanoma who responded to targeted or immunotherapy. The authors found that ME for melanoma is associated with a longer overall survival (OS) in...

Read More

Looking for patients with advanced melanomas to trial an experimental treatment in combination with pembrolizumab.

Looking for patients with advanced melanomas to trial an experimental treatment in combination with pembrolizumab.

Posted by on Sep 6, 2020 in Melanoma | 0 comments

In a nutshell This trial is aiming to examine the effectiveness of APG-115 with pembrolizumab (Keytruda) in the treatment of metastatic melanoma. The main outcomes to be measured will be the maximum dose tolerated and the overall response to the drug. This trial is recruiting in multiple locations in the United States. The details...

Read More

COVID-19 with Cancer

COVID-19 with Cancer

Posted by on Jul 31, 2020 in Blog, Breast cancer, Colorectal cancer, Coronavirus / COVID-19, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 3 comments

Recent research presented at a virtual meeting of the American Association for Cancer Research 1 indicates the need for greater care and continued social distancing for those who are in treatment for cancer and – in one study that was presented – those who have a recent history of cancer (the research looked at people from 2015 to the...

Read More

Treating BRAFV600 mutation-positive advanced melanoma with atezolizumab, vemurafenib, and cobimetinib

Treating BRAFV600 mutation-positive advanced melanoma with atezolizumab, vemurafenib, and cobimetinib

Posted by on Jul 12, 2020 in Melanoma | 0 comments

In a nutshell The study evaluated whether the combination of atezolizumab (Tecentriq), vemurafenib (Zelboraf), and cobimetinib (Cotellic) or AVC can effectively treat patients with BRAFV600 mutation-positive advanced melanoma (AM). The authors found that this combination was safe and effective as an initial treatment in such...

Read More

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Posted by on Jun 28, 2020 in Melanoma | 0 comments

In a nutshell The study monitored the occurrence of possible immune-related side effects (irSEs) in patients with advanced melanoma under single and combination therapy of ipilimumab (I; Yervoy), nivolumab (N; Opdivo), and pembrolizumab (P; Keytruda). The authors found that combination therapy increases the frequency of irSEs. Some background...

Read More

Can biological therapies nivolumab and ipilimumab prevent stage IV melanoma from returning?

Can biological therapies nivolumab and ipilimumab prevent stage IV melanoma from returning?

Posted by on Jun 6, 2020 in Melanoma | 0 comments

In a nutshell This study examined if biological therapies nivolumab (Opdivo) and ipilimumab (Yervoy) could safely prevent cancer return in patients with stage IV melanoma that has been surgically removed. The results showed that nivolumab and ipilimumab were effective at preventing recurrence but nivolumab alone was safer for patients. Some...

Read More

How common are allergic reactions to different biological therapies in patients with advanced melanoma?

How common are allergic reactions to different biological therapies in patients with advanced melanoma?

Posted by on May 16, 2020 in Melanoma | 0 comments

In a nutshell This study compared the frequency of allergic reactions to different doses of three biological therapies in patients with advanced melanoma. The authors found that different doses of the three drugs reduced the number of allergic reactions. Some background Biological therapy has significantly improved treatment results for patients...

Read More

What gut-related side effects do immunotherapy drugs and chemotherapy cause patients with cancer?

Posted by on Apr 14, 2020 in Melanoma | 0 comments

In a nutshell This study examined if certain immunotherapy drugs increased the risk of developing side effects in the gut in patients with cancer also receiving chemotherapy. The results showed that immunotherapy drugs increased the risks of developing gut-related side effects compared to chemotherapy alone. Some background...

Read More